Sources | Names Used |
---|---|
CTRPv2 | BRD9876:MK-1775 (4:1 mol/mol) |
PharmacoGx | BRD9876:MK-1775 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZBTB40 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.003 |
mRNA | ARMC12 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.003 |
mRNA | TICRR | CTRPv2 | pan-cancer | AAC | 0.33 | 0.003 |
mRNA | STK40 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.003 |
mRNA | RPS24 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.003 |
mRNA | CCDC150 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.003 |
mRNA | RBBP5 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.003 |
mRNA | KRTAP12-1 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.003 |
mRNA | TGFBR3 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.003 |
mRNA | RP11-15H20.8 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.003 |